[Clinical trial of a new drug, Meprotixol, with double blind crossover technic with effective compound and placebo. A research project in general practice. General notice].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008722:Methods; D008875:Middle Aged; D010919:Placebos; D012107:Research Design; D052256:Tendinopathy / Q000188:drug therapy; D013892:Thioxanthenes / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010919:Placebos; D013892:Thioxanthenes
Klinisk utprøving av et nytt medikament, Meprotixol, med "dobbeltblind crossover"-teknikk mot virksomt stoff og placebo. Et forskningsprosjekt i almenpraksis. Generell omtale.